Back

Publications

2025/08/08
Taxes américaines : quelle marge de manœuvre pour les groupes pharmaceutiques ?

Interview de Nicolas Bürki, analyste-gérant en actions suisses à la banque.

 

Lien de l'interview

Related publications

Impact of CRD VI on Swiss banks: Strategic implications and market positioning

Impact of CRD VI on Swiss banks: Strategic implications and market positioning

The upcoming implementation of the European Union’s Capital Requirements Directive VI (CRD VI) is set to reshape the operating...
Read more
Market Insight con Adi Pane - CARF, l’equivalente del CRS per le cryptovalute
Investment outlooks

Market Insight by Adi Pane - CARF, the CRS equivalent for crypto

For over a decade, part of crypto’s appeal, particularly for cross-border capital, rested on structural opacity. Decentralisation...
Read more
All publications